We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

103 hedge funds and large institutions have $586M invested in Aravive, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 6

136% more call options, than puts

Call options by funds: $6.31M | Put options by funds: $2.68M

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

47% more capital invested

Capital invested by funds: $399M → $586M (+$187M)

37% more funds holding

Funds holding: 75103 (+28)

22% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 27

Holders
103
Holders Change
+28
Holders Change %
+37.33%
% of All Funds
2.56%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.15%
New
39
Increased
33
Reduced
27
Closed
6
Calls
$6.31M
Puts
$2.68M
Net Calls
+$3.64M
Net Calls Change
+$3.53M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$386K -$23.9K -227 -7%
UBS Group
77
UBS Group
Switzerland
$367K +$302K +2,862 New
Jacobs Levy Equity Management
78
Jacobs Levy Equity Management
New Jersey
$320K -$31.6K -300 -11%
HCM
79
Highbridge Capital Management
New York
$281K -$285K -2,701 -55%
VOYA Investment Management
80
VOYA Investment Management
Georgia
$253K
GT
81
Glenmede Trust
Pennsylvania
$248K +$205K +1,942 New
Citigroup
82
Citigroup
New York
$245K -$558K -5,291 -73%
Simplex Trading
83
Simplex Trading
Illinois
$222K +$183K +1,739 New
CSS
84
Cubist Systematic Strategies
Connecticut
$213K +$175K +1,660 New
Bank of America
85
Bank of America
North Carolina
$203K +$52.7K +500 +46%
PCM
86
Prelude Capital Management
New York
$178K +$85.3K +809 +139%
SG Americas Securities
87
SG Americas Securities
New York
$158K -$108K -1,027 -45%
Legal & General Group
88
Legal & General Group
United Kingdom
$156K -$1.58K -15 -1%
Canada Life
89
Canada Life
Manitoba, Canada
$96K +$79.1K +750 New
AIM
90
Acrospire Investment Management
Illinois
$52K -$5.27K -50 -11%
AIP
91
Ameritas Investment Partners
Nebraska
$50K +$41.4K +393 New
Bank of Montreal
92
Bank of Montreal
Ontario, Canada
$40K
Barclays
93
Barclays
United Kingdom
$37K -$9.49K -90 -24%
Group One Trading
94
Group One Trading
Illinois
$22K +$18.2K +173 New
Royal Bank of Canada
95
Royal Bank of Canada
Ontario, Canada
$20K -$42.1K -399 -72%
MA
96
MUFG Americas
New York
$13K +$10.4K +99 New
FPF
97
FNY Partners Fund
New York
$12K +$10.2K +97 New
Nisa Investment Advisors
98
Nisa Investment Advisors
Missouri
$11K +$8.75K +83 New
FMA
99
FNY Managed Accounts
New York
$6K +$5.27K +50 New
BNP Paribas Financial Markets
100
BNP Paribas Financial Markets
France
$5.53K -$5.91K -56 -57%

ARAV Hedge Fund Activity: Q1 2017 in Review

103 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2017, worth a combined $586M — up 47% from $399M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ARAV positions and 6 closed out — a net gain of 33 holders — while 33 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $41.5M. The largest seller was Sofinnova Management VIII, cutting an estimated $14M.

  • 103 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2017, up from 75 in Q4 2016.
  • Funds reported $586M of Aravive, Inc. Common Stock stock for Q1 2017, up 47% quarter-over-quarter.
  • 39 funds opened new Aravive, Inc. Common Stock positions in Q1 2017 and 6 closed out, a net change of +33 holders.
  • The largest Aravive, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $41.5M added.
  • The largest Aravive, Inc. Common Stock seller in Q1 2017 was Sofinnova Management VIII, an estimated $14M sold.

Based on aggregated 13F filings for Q1 2017.